Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins

被引:59
作者
Tang, J
Olive, M
Pulmanausahakul, R
Schnell, M
Flornenberg, N
Eisenlohr, L
Flomenberg, P
机构
[1] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
adenovirus; hexon; CD8 T lymphocytes; CTL; HLA A2; epitopes; immunotherapy; stem cell transplantation;
D O I
10.1016/j.virol.2006.01.024
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adenoviruses (Ads) cause fatal disease in allogeneic stem cell transplant recipients, but there is no established therapy. Ad-specific CD8(+) T cells were detected in PBMC from healthy adults at a mean frequency of 77 per 10(5) CD8(+) T cells (range 8-260) by interferon-gamma ELISPOT and cytokine flow cytometry assays. CD8(+) T cell lines from 7 of 7 donors exhibited MHC-class-I-restricted killing of targets expressing the capsid protein hexon. In contrast, cytotoxicity against the capsid proteins fiber and penton base was weaker or not detected. Two HLA-A2-restricted hexon epitopes and one HLA-B-restricted epitope were identified, all of which are adjacent to or overlap an HLA-DP4-restricted epitope in the highly conserved C-terminus. Thus, hexon is the immunodominant T cell target among capsid proteins and contains multiple C-terminal epitopes conserved among serotypes. These data support evaluation of donor lymphocyte infusions for treatment of Ad disease post-transplant. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:312 / 322
页数:11
相关论文
共 38 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]  
Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984
[3]   Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells [J].
Bunde, T ;
Kirchner, A ;
Hoffmeister, B ;
Habedank, D ;
Hetzer, R ;
Cherepnev, G ;
Proesch, S ;
Reinke, P ;
Volk, HD ;
Lehmkuhl, H ;
Kern, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1031-1036
[4]   Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? [J].
Chakrabarti, S ;
Collingham, KE ;
Fegan, CD ;
Pillay, D ;
Milligan, DW .
BONE MARROW TRANSPLANTATION, 2000, 26 (03) :305-307
[5]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[6]   Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery [J].
Chakrabarti, S ;
Mautner, V ;
Osman, H ;
Collingham, KE ;
Fegan, CD ;
Klapper, PE ;
Moss, PAH ;
Milligan, DW .
BLOOD, 2002, 100 (05) :1619-1627
[7]   CHARACTERIZATION OF HUMAN PROLIFERATIVE T-CELL RESPONSES TO ADENOVIRUS [J].
FLOMENBERG, P ;
PIASKOWSKI, V ;
TRUITT, RL ;
CASPER, JT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1090-1096
[8]   Human adenovirus-specific CD8(+) T-cell responses are not inhibited by E3-19K in the presence of gamma interferon [J].
Flomenberg, P ;
Piaskowski, V ;
Truitt, RL ;
Casper, JT .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6314-6322
[9]   INCREASING INCIDENCE OF ADENOVIRUS DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
FLOMENBERG, P ;
BABBITT, J ;
DROBYSKI, WR ;
ASH, RC ;
CARRIGAN, DR ;
SEDMAK, GV ;
MCAULIFFE, T ;
CAMITTA, B ;
HOROWITZ, MH ;
BUNIN, N ;
CASPER, JT .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :775-781
[10]  
HONG JS, 1991, VIROLOGY, V185, P758